TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer
Clinical trial NCT04094896 · UNKNOWN
Trial details
- NCT number
- NCT04094896
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-17
- Primary completion
- 2022-09-17
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.